Previous close | 0.4800 |
Open | 0.3000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 12.50 |
Expiry date | 2024-05-17 |
Day's range | 0.3000 - 0.5000 |
Contract range | N/A |
Volume | |
Open interest | 346 |
Despite foreign exchange headwinds, Nu Skin navigates through economic pressures with strategic innovations and robust segment growth.
Nu Skin (NUS) delivered earnings and revenue surprises of 80% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Personal care company Nu Skin (NYSE:NUS) missed analysts' expectations in Q1 CY2024, with revenue down 13.3% year on year to $417.3 million. Next quarter's revenue guidance of $437.5 million also underwhelmed, coming in 3.7% below analysts' estimates. It made a non-GAAP profit of $0.09 per share, down from its profit of $0.37 per share in the same quarter last year.